Correspondence 0001493152-25-008125 from Youlife Group Inc. (YOUL)
Youlife Group Inc.
Date: Feb. 25, 2025 · CIK: 0002028177 · Accession: 0001493152-25-008125
AI Filing Summary & Sentiment
Referenced dates: February 11, 2025
Show Raw Text
CORRESP
1
filename1.htm
Unit
2901, 29F, Tower C
Beijing
Yintai Centre
No.
2 Jianguomenwai Avenue
Chaoyang
District, Beijing 100022
People’s
Republic of China
Phone:
86-10-6529-8300
Fax:
86-10-6529-8399
Website:
www.wsgr.com
中国北京市朝阳区建国门外大街2号
银泰中心写字楼C座29层2901室
邮政编码:
100022
电话:
86-10-6529-8300
传真:
86-10-6529-8399
网站:
www.wsgr.com
Confidential
February
25, 2025
Attention:
Ms.
Valeria Franks
Mr.
Adam Phippen
Ms.
Kate Beukenkamp
Ms.
Lilyanna Peyser
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Trade & Services
Washington,
D.C. 20549
Re:
Youlife
Group Inc.
Registration Statement on Form F-4
CIK
No. 0002028177
Dear
Ms. Franks, Mr. Phippen, Ms. Beukenkamp and Ms. Peyser:
On
behalf of our client, Youlife Group Inc., an exempted company incorporated in the Cayman Islands (the “Company”),
we are hereby submitting to the staff (the “Staff”) of the Securities and Exchange Commission (the
“Commission”) this letter setting forth the Company’s responses to the comments contained in the
Staff’s letter dated February 11, 2025 on the Company’s Amendment No. 3 to Draft Registration Statement on Form F-4
submitted to the Commission on January 17, 2025 (the “Draft Registration Statement”). Concurrently with the
submission of this letter, the Company is filing its registration statement on Form F-4 (the “Registration
Statement”) and certain exhibits via EDGAR to the Commission.
To
facilitate your review, we have separately emailed you a courtesy copy of the Registration Statement marked to show changes to
Draft Registration Statement.
The
Staff’s comments are repeated below in bold and are followed by the Company’s responses. We have included page references
in the Registration Statement where the disclosure addressing a particular comment appears. Capitalized terms used but not otherwise
defined herein have the meanings set forth in the Registration Statement.
Wilson
Sonsini Goodrich & Rosati, Professional Corporation
威尔逊·桑西尼·古奇·罗沙迪律师事务所
austin beijing boston BOULDER brussels hong kong london los angeles new york palo alto
SALT LAKE CITY san diego san francisco seattle shanghai washington, dc wilmington, de
Page
2
Amendment
No. 3 to Draft Registration Statement on Form F-4
Dilution, page 23
1. We
reviewed your response and revised disclosure in response to prior comment 5. The revisions
did not address the disclosure requirement of Item 1604(c) of Regulation S-K. The SPAC’s
net tangible book value per share, as adjusted, should depict the net tangible assets per
share that the SPAC will contribute to the post-combination entity. The pro forma amounts
presented here do not satisfy the Item 1604(c) requirements. Please revise to present in
a tabular form your calculations of the numerator and denominator used to arrive at the SPAC’s
net tangible book value per share, as adjusted. The calculation of the numerator (SPAC’s
net tangible book value, as adjusted) should begin with the SPAC’s historical net tangible
book value as of the most recent balance sheet date, and include material adjustments, such
as probable or consummated transactions and other effects from the de-SPAC transaction (e.g.,
all financing transactions, payment of deferred underwriting costs, payments of compensation
to a SPAC sponsor, de-SPAC transaction costs, reclassifications from the trust account to
cash, etc.), while excluding the de-SPAC transaction itself. The calculation of the denominator
(total shares, as adjusted) should separately list each item (e.g., Founder Shares, Public
Shares, Earnout Shares issued to Sponsor, shares issued upon conversions, other share adjustments,
etc.), excluding the de-SPAC transaction itself, that is probable of occurring prior to or
in conjunction with the de-SPAC transaction. Refer to Section II.D.3 of SEC Release No. 33-11265.
Response: In response to the Staff’s comment, the Company has revised
the disclosure on pages 23 and 24 of the Registration Statement.
2.
Please tell us how you calculated the number of shares underlying Public Rights. In this regard, tell us
if Public Rights are terminated upon redemption.
Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that, in connection with its initial public offering,
Distoken issued 6,900,000 Public Rights. Each Public Right entitles the holder to receive one-tenth (1/10) of one ordinary share upon
the consummation of the initial business combination for a total of 690,000 ordinary shares. Accordingly, each issued and outstanding
Public Right will automatically convert into one-tenth (1/10) of one Pubco Class A Ordinary Share upon consummation of the business combination
(in the form of ADSs) for a total of 690,000 Pubco Class A Ordinary Shares. Pubco will not issue fractional shares in exchange for the
Public Rights. The Public Rights terminate upon such conversion.
3.
Your
disclosure on page 21 states that the maximum redemption scenario does not take into account the Minimum Cash Condition. The same
disclosure is made on page 185 of your Unaudited Pro Forma Condensed Combined Financial Information. Please tell us why your calculations
are appropriate considering under Item 1604(c) of Regulation S-K, redemption levels that are not possible should not be selected.
Refer to Section II.D.3 of SEC Release No. 33-11265.
Response: In response to
the Staff’s comment, the Company respectfully advises the Staff that Youlife International Holdings Inc. currently intends to
waive the Minimum Cash Condition if it is not met, and therefore the maximum redemption scenario assumes that the Minimum Cash Condition
is not met but waived by Youlife. The Company has accordingly revised the disclosure on pages 21, 22, 45, 72, 120 and 190 of the Registration Statement.
Summary
of the Proxy Statement/Prospectus
Permissions
Required from the PRC Authorities for Youlife’s Operations, page 58
4.
We note your revisions in response to comment 2. Please revise this section, as you did the following section,
to state whether any permission or approvals sought by you or your subsidiaries in connection with operating your business have been
denied.
Response:
In response to the Staff’s comment, the Company has revised the disclosure on pages 61, 93 and 94 of the Registration
Statement.
Page
3
Unaudited
Pro Forma Condensed Combined Financial Information, page 184
5.
Please tell us why the pro forma financial information does not use Distoken’s financial information
as of and for the nine months ended September 30, 2024.
Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it believes the age of the pro forma financial
information shall follow that of Youlife International Holdings Inc. or Youlife Group Inc., as the registrant, instead of Distoken. According
to Section 6220.8 Age of Pro Formas in Cross-border Business Combinations of SEC’s Financial Reporting Manual, the age of
the pro forma financial information included in a registration statement is based on the age of financial statements requirement applicable
to the registrant. Accordingly, the age of the pro forma financial information included in the Registration Statement shall be
based on the age of financial statements requirement applicable to the registrant, which is as of and for the six months ended June 30,
2024.
Youlife
Group Inc. Consolidated Financial Statements
2.
Summary of significant accounting policies, page F-104
6.
Please disclose your fiscal year end.
Response:
In response to the Staff’s comment, the Company has revised the disclosure on page F-105 of the Registration Statement
on summary of significant accounting policies.
***
Page
4
If
you have any questions regarding the Registration Statement, please contact Ms. Dan Ouyang by telephone at 86-10-6529-8308 or
via e-mail at douyang@wsgr.com.
Very
truly yours,
/s/
Dan Ouyang
Dan
Ouyang
Enclosures
cc:
Lidong
Zhu, Chief Financial Officer, Youlife Group Inc.
Jian
Zhang, Chairman and Chief Executive Officer, Distoken Acquisition Corporation
K.
Ronnie Li, Partner, Wilson Sonsini Goodrich & Rosati, Professional Corporation
Richard
I. Anslow, Esq., Partner, Ellenoff Grossman & Schole LLP